Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutations.
作者： Gad Rennert , Shantih Bisland-Naggan , Ofra Barnett-Griness , Naomi Bar-Joseph , Shiyu Zhang
DOI: 10.1056/NEJMOA070608
关键词: Population 、 Oncology 、 Medicine 、 Breast cancer 、 Tumor suppressor gene 、 Mammary gland 、 Pathology 、 Mutation (genetic algorithm) 、 Pathological 、 Internal medicine 、 Medical record 、 Cancer registry
摘要: Background Some features of breast cancer in women with a BRCA1 mutation suggest that hereditary breast cancer has a poor outcome. We conducted a national population-based …
ralf-kollinger.de参考文章(17)
E. Steliarova-Foucher, M. Laversanne, J. Ferlay, D. Forman, S. Antoni, Freddie Ian Bray, C. Gombe Mbalawa, B. Kohler, M. Piñeros, D. H. Brewster, I. Soerjomataram, R. Swaminathan, Cancer Incidence in Five Continents ,(1997)
Graciela Kuperstein, William D Foulkes, Parviz Ghadirian, Jalil Hakimi, Steven A Narod, A rapid fluorescent multiplexed-PCR analysis (FMPA) for founder mutations in the BRCA1 and BRCA2 genes. Clinical Genetics. ,vol. 57, pp. 213- 220 ,(2001) , 10.1034/J.1399-0004.2000.570307.X
Dominique Stoppa-Lyonnet, Yan Ansquer, Hélène Dreyfus, Chantal Gautier, Marion Gauthier-Villars, Edwige Bourstyn, Krishna B. Clough, Henri Magdelénat, Pierre Pouillart, Anne Vincent-Salomon, Alain Fourquet, Bernard Asselain, Familial Invasive Breast Cancers: Worse Outcome Related to BRCA1 Mutations Journal of Clinical Oncology. ,vol. 18, pp. 4053- 4059 ,(2000) , 10.1200/JCO.2000.18.24.4053
Mark E Robson, Pierre O Chappuis, Jaya Satagopan, Nora Wong, Jeff Boyd, John R Goffin, Clifford Hudis, David Roberge, Larry Norton, Louis R Bégin, Kenneth Offit, William D Foulkes, A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment Breast Cancer Research. ,vol. 6, pp. 1- 10 ,(2003) , 10.1186/BCR658
Catherine M. Phelan, Elaine Kwan, Elaine Jack, Song Li, Cindy Morgan, Jennifer Aubé, Danielle Hanna, Steven A. Narod, A low frequency of non-founder BRCA1 mutations in Ashkenazi Jewish breast-ovarian cancer families. Human Mutation. ,vol. 20, pp. 352- 357 ,(2002) , 10.1002/HUMU.10123
Mahmoud El-Tamer, Donna Russo, Andrea Troxel, Lourdes P. Bernardino, Robert Mazziotta, Alison Estabrook, Beth-Ann Ditkoff, Freya Schnabel, Mahesh Mansukhani, Survival and recurrence after breast cancer in BRCA1/2 mutation carriers. Annals of Surgical Oncology. ,vol. 11, pp. 157- 164 ,(2004) , 10.1245/ASO.2004.05.018
Hannaleena Eerola, Pia Vahteristo, Laura Sarantaus, Pentti Kyyr�nen, Seppo Pyrh�nen, Carl Blomqvist, Eero Pukkala, Heli Nevanlinna, Risto Sankila, Survival of breast cancer patients in BRCA1, BRCA2, and non-BRCA1/2 breast cancer families: a relative survival analysis from Finland. International Journal of Cancer. ,vol. 93, pp. 368- 372 ,(2001) , 10.1002/IJC.1341
Pål Møller, Åke Borg, D Gareth Evans, Neva Haites, Marta M Reis, Hans Vasen, Elaine Anderson, C Michael Steel, Jaran Apold, David Goudie, Anthony Howell, Fiona Lalloo, Lovise Mæhle, Helen Gregory, Ketil Heimdal, None, Survival in prospectively ascertained familial breast cancer: Analysis of a series stratified by tumour characteristics, BRCA mutations and oophorectomy International Journal of Cancer. ,vol. 101, pp. 555- 559 ,(2002) , 10.1002/IJC.10641
Carole Oddoux, Jeffery P. Struewing, C. Mark Clayton, Susan Neuhausen, Lawrence C. Brody, Michael Kaback, Bruce Haas, Larry Norton, Patrick Borgen, Suresh Jhanwar, David Goldgar, Harry Ostrer, Kenneth Offit, The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1 Nature Genetics. ,vol. 14, pp. 188- 190 ,(1996) , 10.1038/NG1096-188
Ó.T. Jóhannsson, I. Idvall, C. Anderson, Å. Borg, R.B. Barkardóttir, V. Egilsson, H. Olsson, Tumour biological features of BRCA1-induced breast and ovarian cancer. European Journal of Cancer. ,vol. 33, pp. 362- 371 ,(1997) , 10.1016/S0959-8049(97)89007-7